Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

To eliminate onchocerciasis-associated morbidity, it is important to identify areas where there is still high ongoing <i>Onchocerca volvulus</i> transmission. Between 2015 and 2021, door-to-door surveys were conducted in onchocerciasis-endemic villages in Cameroon, the Democratic Republi...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Alfred Dusabimana, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, Bruno P. Mmbando, Stephen Raimon Jada, Annelies Boven, Eric De Smet, Tony Ukety, Alfred K. Njamnshi, Anne Laudisoit, Steven Abrams, Robert Colebunders
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	MDPI AG 2022-02-01
Reeks:	Pathogens
Onderwerpen:	onchocerciasis onchocerciasis-associated epilepsy epilepsy prevalence incidence ivermectin OV16 antibodies
Online toegang:	https://www.mdpi.com/2076-0817/11/3/281

Gelijkaardige items

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
door: Alfred Dusabimana, et al.
Gepubliceerd in: (2020-10-01)

Epidemiology of epilepsy in Wulu County, an onchocerciasis-endemic area in South Sudan
door: Joseph Nelson Siewe Fodjo, et al.
Gepubliceerd in: (2024-09-01)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
door: Joseph N. F. Siewe, et al.
Gepubliceerd in: (2019-01-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
door: Michel Mandro, et al.
Gepubliceerd in: (2020-03-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
door: Robert Colebunders, et al.
Gepubliceerd in: (2019-10-01)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>
door: Alfred Dusabimana, et al.
Gepubliceerd in: (2020-12-01)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
door: Joseph Nelson Siewe Fodjo, et al.
Gepubliceerd in: (2018-12-01)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
door: Joseph Nelson Siewe Fodjo, et al.
Gepubliceerd in: (2019-02-01)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
door: Nolbert Gumisiriza, et al.
Gepubliceerd in: (2020-03-01)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
door: Robert Colebunders, et al.
Gepubliceerd in: (2022-03-01)

Focus of Ongoing Onchocerciasis Transmission Close to Bangui, Central African Republic
door: Eric de Smet, et al.
Gepubliceerd in: (2020-04-01)

Epilepsy in the onchocerciasis endemic area of Deim Zubeir, South Sudan: a household survey
door: Jurel Payii Mamur, et al.
Gepubliceerd in: (2025-02-01)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
door: Robert Colebunders, et al.
Gepubliceerd in: (2024-01-01)

The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan
door: Sube KL, et al.
Gepubliceerd in: (2024-12-01)

The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey
door: Stephen Raimon Jada, et al.
Gepubliceerd in: (2022-03-01)

Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations
door: Vivian Mushi, et al.
Gepubliceerd in: (2024-01-01)

High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey
door: Stephen Raimon, et al.
Gepubliceerd in: (2021-05-01)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
door: Alfred Dusabimana, et al.
Gepubliceerd in: (2020-07-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
door: Charlotte Boullé, et al.
Gepubliceerd in: (2019-03-01)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
door: Sarah O’Neill, et al.
Gepubliceerd in: (2019-05-01)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
door: Melissa Krizia Vieri, et al.
Gepubliceerd in: (2021-06-01)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
door: Evy Lenaerts, et al.
Gepubliceerd in: (2018-08-01)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
door: Housseini Dolo, et al.
Gepubliceerd in: (2018-12-01)

Ivermectin as a promising therapeutic option for onchocerciasis‐associated epilepsy
door: Mohammad Amin Manavi, et al.
Gepubliceerd in: (2025-02-01)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
door: An Hotterbeekx, et al.
Gepubliceerd in: (2021-07-01)

Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus
door: Sérgio Luiz Bessa Luz, et al.
Gepubliceerd in: (2014-07-01)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
door: Bernis Neneyoh Yengo, et al.
Gepubliceerd in: (2022-06-01)

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
door: Ed Cupp, et al.
Gepubliceerd in: (2019-07-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
door: Joseph Nelson Siewe Fodjo, et al.
Gepubliceerd in: (2019-08-01)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
door: Melissa Krizia Vieri, et al.
Gepubliceerd in: (2021-03-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
door: E N Shu, et al.
Gepubliceerd in: (2004-01-01)

Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone
door: Ibrahim Kargbo-Labour, et al.
Gepubliceerd in: (2024-03-01)

Onchocerciasis then and now: achievements, priorities and challenges
door: Adrian Hopkins
Gepubliceerd in: (2018-01-01)

The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study
door: T. L. Lakwo, et al.
Gepubliceerd in: (2020-04-01)

Seroprevalence of onchocerciasis in Ogun State, Nigeria after ten years of mass drug administration with ivermectin
door: O. A. Surakat, et al.
Gepubliceerd in: (2018-09-01)

Report of the first international workshop on onchocerciasis-associated epilepsy
door: Robert Colebunders, et al.
Gepubliceerd in: (2018-03-01)

Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus [version 2; peer review: 2 approved]
door: Robert Colebunders, et al.
Gepubliceerd in: (2023-12-01)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
door: Kenneth Bentum Otabil, et al.
Gepubliceerd in: (2023-08-01)

Onchocerciasis: the beginning of the end?
door: Adrian Hopkins
Gepubliceerd in: (2019-02-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
door: M. Winnen, et al.